Onlassyn Ibekenov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Onlassyn Ibekenov has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Aman Berkinbay
Kazakh National Medical University
6 shared publications - Abylai Baymakhanov
Faculty of Postgraduate Education, JSC «Asfendiyarov Kazakh National Medical University», Almaty, Kazakhstan
4 shared publications - Bolatbek Baimakhanov
National Scientific Center of Surgery named after A.N. Syzganov
3 shared publications - Alisher Kozhamkul
JSC «Syzganov National Scientific Center of Surgery», Almaty, Republic of Kazakhstan
2 shared publications - Almas Saduakas
National Scientific Center of Surgery, Department of Vascular Surgery. Almaty, Kazakhstan
2 shared publications - Dias Myrzash
JSC «Asfendiyarov Kazakh National Medical University», Almaty, the Republic of Kazakhstan
2 shared publications
Latest Publications
- 30 June 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(28),p. 116-124
ENDOVASCULAR EMBOLIZATION FOR PELVIC VENOUS VARICOSITIES IN WOMEN OF REPRODUCTIVE AGE WITH LIVER CIRRHOSIS: CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES
Introduction. Pelvic venous varicosities (PVV) in women with liver cirrhosis are rare but clinically significant. Portal hypertension and impaired gonadal venous outflow contribute to reflux, dilation, and chronic pelvic pain. In reproductive-age women, PVV may be linked to infertility and adverse obstetric outcomes, emphasizing the importance of timely diagnosis and treatment. Aim. To evaluate the prevalence, clinical characteristics, and surgical outcomes of pelvic venous varicosities in women of reproductive age with liver cirrhosis. Materials and Methods. A retrospective study included 344 women with liver cirrhosis treated at the National Scientific Center of Surgery named after A.N. Syzganov (Almaty, Kazakhstan) between 2019 and 2024. Of them, 61 were of reproductive age (18-45 years), and PVV was diagnosed in 9 patients (2.6%) using Doppler ultrasonography, CT venography, and phlebography. All underwent endovascular ovarian vein embolization with coils and sclerosants. Pain severity was assessed using the visual analogue scale (VAS); reproductive outcomes were also analyzed. The Wilcoxon signed-rank test was applied to compare pre- and post-procedure data. Differences were considered statistically significant at p < 0.05. Results. Mean age was 38.2 ± 6.1 years. Esophageal varices were present in 6 women (66.7%), ascites in 3 (33.3%), and splenomegaly in 5 (55.6%). Portal hypertension-related complications were more common in Child–Pugh classes B–C (77.8% vs. 33.3% in class A; p = 0.04). Obstetric complications were reported in 3 patients (42.8%), and secondary infertility in 2 (28.6%). Severe PVV (Hiromura II–III) was more frequent in multiparous women (71.4% vs. 33.3%; p = 0.048). VAS decreased from 6.8 at baseline to 3.2 on day 3, 2.8 at 1 month, and 2.4 at 3 months (p < 0.001). Clinical improvement included reduced pelvic pain (77.8%), dyspareunia (66.7%), normalization of cycles (22.2%), and one pregnancy. No major complications were observed; one patient required re-embolization. Overall effectiveness reached 88.9%. Conclusions. PVV in women with cirrhosis is uncommon but impactful. Ovarian vein embolization is a safe and effective treatment method for PVV, providing sustained pain relief, improved quality of life, and partial restoration of reproductive potential. Введение. Тазовые венозные варикозы (ТВВ) у женщин с циррозом печени являются редкой, но клинически значимой патологией. Портальная гипертензия и нарушение оттока по гонадным венам способствуют развитию венозного рефлюкса, дилатации сосудов и формированию хронического тазового болевого синдрома. У женщин репродуктивного возраста ТВВ могут быть связаны с бесплодием и неблагоприятными акушерскими исходами, что подчёркивает важность своевременной диагностики и лечения. Цель. Оценить распространённость, клинические особенности и результаты хирургического лечения тазовых венозных варикозов у женщин репродуктивного возраста с циррозом печени. Материалы и методы.Ретроспективное исследование включало 344 женщин с циррозом печени, проходивших лечение в Национальном научном центре хирургии имени А.Н. Сызганова (г. Алматы, Казахстан) в период с 2019 по 2024 годы. Из них 61 пациентка находилась в репродуктивном возрасте (18–45 лет), у 9 (2,6%) были диагностированы ТВВ с использованием допплеровского ультразвукового исследования, КТ-венографии и флебографии. Всем пациенткам выполнена эндоваскулярная эмболизация яичниковых вен с применением спиралей и склерозантов. Интенсивность болевого синдрома оценивалась по визуально-аналоговой шкале (ВАШ), также анализировались репродуктивные исходы. Для сравнения показателей до и после вмешательства использовался критерий Уилкоксона. Статистически значимыми считались различия при p < 0,05. Результаты. Средний возраст пациенток составил 38,2 ± 6,1 года. Варикозное расширение вен пищевода выявлено у 6 пациенток (66,7%), асцит — у 3 (33,3%), спленомегалия — у 5 (55,6%). Осложнения портальной гипертензии достоверно чаще наблюдались у пациенток с циррозом класса Child–Pugh B–C по сравнению с классом A (77,8% против 33,3%; p = 0,04). Акушерские осложнения отмечены у 3 пациенток (42,8%), вторичное бесплодие — у 2 (28,6%). Тяжёлые формы ТВВ (II–III степень по Hiromura) чаще встречались у многорожавших женщин (71,4% против 33,3%; p = 0,048). Показатель ВАШ достоверно снизился с исходного уровня 6,8 до...
- 30 June 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(28),p. 116-124
ENDOVASCULAR EMBOLIZATION FOR PELVIC VENOUS VARICOSITIES IN WOMEN OF REPRODUCTIVE AGE WITH LIVER CIRRHOSIS: CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES
Introduction. Pelvic venous varicosities (PVV) in women with liver cirrhosis are rare but clinically significant. Portal hypertension and impaired gonadal venous outflow contribute to reflux, dilation, and chronic pelvic pain. In reproductive-age women, PVV may be linked to infertility and adverse obstetric outcomes, emphasizing the importance of timely diagnosis and treatment. Aim. To evaluate the prevalence, clinical characteristics, and surgical outcomes of pelvic venous varicosities in women of reproductive age with liver cirrhosis. Materials and Methods. A retrospective study included 344 women with liver cirrhosis treated at the National Scientific Center of Surgery named after A.N. Syzganov (Almaty, Kazakhstan) between 2019 and 2024. Of them, 61 were of reproductive age (18-45 years), and PVV was diagnosed in 9 patients (2.6%) using Doppler ultrasonography, CT venography, and phlebography. All underwent endovascular ovarian vein embolization with coils and sclerosants. Pain severity was assessed using the visual analogue scale (VAS); reproductive outcomes were also analyzed. The Wilcoxon signed-rank test was applied to compare pre- and post-procedure data. Differences were considered statistically significant at p < 0.05. Results. Mean age was 38.2 ± 6.1 years. Esophageal varices were present in 6 women (66.7%), ascites in 3 (33.3%), and splenomegaly in 5 (55.6%). Portal hypertension-related complications were more common in Child–Pugh classes B–C (77.8% vs. 33.3% in class A; p = 0.04). Obstetric complications were reported in 3 patients (42.8%), and secondary infertility in 2 (28.6%). Severe PVV (Hiromura II–III) was more frequent in multiparous women (71.4% vs. 33.3%; p = 0.048). VAS decreased from 6.8 at baseline to 3.2 on day 3, 2.8 at 1 month, and 2.4 at 3 months (p < 0.001). Clinical improvement included reduced pelvic pain (77.8%), dyspareunia (66.7%), normalization of cycles (22.2%), and one pregnancy. No major complications were observed; one patient required re-embolization. Overall effectiveness reached 88.9%. Conclusions. PVV in women with cirrhosis is uncommon but impactful. Ovarian vein embolization is a safe and effective treatment method for PVV, providing sustained pain relief, improved quality of life, and partial restoration of reproductive potential. Введение. Тазовые венозные варикозы (ТВВ) у женщин с циррозом печени являются редкой, но клинически значимой патологией. Портальная гипертензия и нарушение оттока по гонадным венам способствуют развитию венозного рефлюкса, дилатации сосудов и формированию хронического тазового болевого синдрома. У женщин репродуктивного возраста ТВВ могут быть связаны с бесплодием и неблагоприятными акушерскими исходами, что подчёркивает важность своевременной диагностики и лечения. Цель. Оценить распространённость, клинические особенности и результаты хирургического лечения тазовых венозных варикозов у женщин репродуктивного возраста с циррозом печени. Материалы и методы.Ретроспективное исследование включало 344 женщин с циррозом печени, проходивших лечение в Национальном научном центре хирургии имени А.Н. Сызганова (г. Алматы, Казахстан) в период с 2019 по 2024 годы. Из них 61 пациентка находилась в репродуктивном возрасте (18–45 лет), у 9 (2,6%) были диагностированы ТВВ с использованием допплеровского ультразвукового исследования, КТ-венографии и флебографии. Всем пациенткам выполнена эндоваскулярная эмболизация яичниковых вен с применением спиралей и склерозантов. Интенсивность болевого синдрома оценивалась по визуально-аналоговой шкале (ВАШ), также анализировались репродуктивные исходы. Для сравнения показателей до и после вмешательства использовался критерий Уилкоксона. Статистически значимыми считались различия при p < 0,05. Результаты. Средний возраст пациенток составил 38,2 ± 6,1 года. Варикозное расширение вен пищевода выявлено у 6 пациенток (66,7%), асцит — у 3 (33,3%), спленомегалия — у 5 (55,6%). Осложнения портальной гипертензии достоверно чаще наблюдались у пациенток с циррозом класса Child–Pugh B–C по сравнению с классом A (77,8% против 33,3%; p = 0,04). Акушерские осложнения отмечены у 3 пациенток (42,8%), вторичное бесплодие — у 2 (28,6%). Тяжёлые формы ТВВ (II–III степень по Hiromura) чаще встречались у многорожавших женщин (71,4% против 33,3%; p = 0,048). Показатель ВАШ достоверно снизился с исходного уровня 6,8 до...
- Open Access
- 15 January 2026
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 23 (1) , 79-92
Inguinal Hernia: Modern Surgical Treatment Methods (Systematic Review and Meta-Analysis)
Background: Inguinal hernia (IH) is among the most common conditions in general surgery, accounting for up to 75–80% of anterior abdominal wall hernias. Open Lichtenstein repair remains widely used but is associated with postoperative pain and longer recovery. The increasing adoption of laparoscopic (TAPP, TEP) and robotic (R-TAPP, R-TEP) techniques aims to improve perioperative and functional outcomes. Objective: To perform a systematic review and meta-analysis comparing open, laparoscopic, and robotic inguinal hernia repair with respect to operative parameters, postoperative outcomes, and recurrence. Methods: This study was conducted according to PRISMA 2020 and AMSTAR 2 guidelines. PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar were searched for studies published between January 2015 and August 2025. Outcomes included operative time, recurrence, postoperative complications, hospital stay, and readmission. Pooled estimates were calculated as odds ratios (OR) or standardized mean differences (SMD) with 95% confidence intervals (CI). Results: Twenty-one comparative studies comprising 66,274 patients were included: 2,188 (3.3%) open, 55,145 (83.2%) laparoscopic, and 8,941 (13.5%) robotic repairs. Operative time was longest for robotic repair, exceeding open and laparoscopic approaches by approximately 40% and 20%, respectively. Minimally invasive techniques significantly reduced postoperative complications (open 7.3–7.8%, laparoscopic 5.6%, robotic 4.1%) and shortened hospital stay (open 2.1 days, laparoscopic 1.4 days, robotic 1.1 days). Recurrence rates were low across all techniques (open 2.4%, laparoscopic 1.4%, robotic 1.2%). Pooled analysis demonstrated higher odds of recurrence for robotic versus open repair (OR = 3.41; 95% CI 1.47–7.89), while robotic and laparoscopic approaches showed equivalent recurrence risk (OR = 1.04; p = 0.86). Readmission rates remained low (<2%) and comparable between minimally invasive techniques. Conclusion: Laparoscopic and robotic inguinal hernia repair provide superior perioperative outcomes compared with open surgery. Robotic repair offers the lowest complication rates and shortest hospitalization, though slightly longer operative time and higher pooled odds of recurrence versus open repair warrant cautious interpretation and further long-term studies.
- 15 January 2026
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 23 (1) , 79-92
Open AccessInguinal Hernia: Modern Surgical Treatment Methods (Systematic Review and Meta-Analysis)
Background: Inguinal hernia (IH) is among the most common conditions in general surgery, accounting for up to 75–80% of anterior abdominal wall hernias. Open Lichtenstein repair remains widely used but is associated with postoperative pain and longer recovery. The increasing adoption of laparoscopic (TAPP, TEP) and robotic (R-TAPP, R-TEP) techniques aims to improve perioperative and functional outcomes. Objective: To perform a systematic review and meta-analysis comparing open, laparoscopic, and robotic inguinal hernia repair with respect to operative parameters, postoperative outcomes, and recurrence. Methods: This study was conducted according to PRISMA 2020 and AMSTAR 2 guidelines. PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar were searched for studies published between January 2015 and August 2025. Outcomes included operative time, recurrence, postoperative complications, hospital stay, and readmission. Pooled estimates were calculated as odds ratios (OR) or standardized mean differences (SMD) with 95% confidence intervals (CI). Results: Twenty-one comparative studies comprising 66,274 patients were included: 2,188 (3.3%) open, 55,145 (83.2%) laparoscopic, and 8,941 (13.5%) robotic repairs. Operative time was longest for robotic repair, exceeding open and laparoscopic approaches by approximately 40% and 20%, respectively. Minimally invasive techniques significantly reduced postoperative complications (open 7.3–7.8%, laparoscopic 5.6%, robotic 4.1%) and shortened hospital stay (open 2.1 days, laparoscopic 1.4 days, robotic 1.1 days). Recurrence rates were low across all techniques (open 2.4%, laparoscopic 1.4%, robotic 1.2%). Pooled analysis demonstrated higher odds of recurrence for robotic versus open repair (OR = 3.41; 95% CI 1.47–7.89), while robotic and laparoscopic approaches showed equivalent recurrence risk (OR = 1.04; p = 0.86). Readmission rates remained low (<2%) and comparable between minimally invasive techniques. Conclusion: Laparoscopic and robotic inguinal hernia repair provide superior perioperative outcomes compared with open surgery. Robotic repair offers the lowest complication rates and shortest hospitalization, though slightly longer operative time and higher pooled odds of recurrence versus open repair warrant cautious interpretation and further long-term studies.
- Open Access
- 21 September 2025
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 22 (5) , 66-72
Comparative Evaluation of Minimally Invasive Surgical Methods for the Treatment of Varicose Vein Disease in the Lower Extremities
Introduction: Varicose vein disease (VVD) of the lower extremities is a widespread condition that significantly affects patients’ quality of life and often leads to complications such as thrombophlebitis, deep vein thrombosis, and chronic venous insufficiency. The development of minimally invasive surgical techniques—such as endovenous laser ablation (EVLA), radiofrequency ablation (RFA), and sclerotherapy—has created opportunities to reduce postoperative complications, shorten recovery time, and improve cosmetic and functional outcomes. Methods: A retrospective study was conducted at the National Scientific Center of Surgery named after A.N. Syzganov in Almaty, Kazakhstan, between January 2019 and December 2024. The study included 481 patients diagnosed with VVD, divided into two groups: Group I (n=305) underwent traditional surgical treatment (ligation and vein stripping), while Group II (n=176) received minimally invasive interventions (EVLA, RFA, or sclerotherapy). Data on demographics, CEAP classification, Doppler ultrasound parameters, intraoperative characteristics, postoperative complications, and recovery time were analyzed. Statistical analysis was performed using t-test, chi-square test, and logistic regression (p<0.05). Results: Minimally invasive methods showed significantly shorter operative times (43.2 vs. 78.6 min), less intraoperative blood loss (48.9 vs. 160.3 ml), and fewer complications (6.8% vs. 16.9%). Postoperative pain (VAS) and hospital stay were significantly lower in the minimally invasive group. However, traditional surgery was more often used in advanced cases (C3–C4 stages). Conclusion: Minimally invasive surgical methods for VVD are associated with fewer complications, faster recovery, and greater patient satisfaction. However, traditional approaches remain essential in severe cases. Individualized treatment planning based on clinical stage and patient characteristics is key to achieving optimal outcomes.
- 21 September 2025
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 22 (5) , 66-72
Open AccessComparative Evaluation of Minimally Invasive Surgical Methods for the Treatment of Varicose Vein Disease in the Lower Extremities
Introduction: Varicose vein disease (VVD) of the lower extremities is a widespread condition that significantly affects patients’ quality of life and often leads to complications such as thrombophlebitis, deep vein thrombosis, and chronic venous insufficiency. The development of minimally invasive surgical techniques—such as endovenous laser ablation (EVLA), radiofrequency ablation (RFA), and sclerotherapy—has created opportunities to reduce postoperative complications, shorten recovery time, and improve cosmetic and functional outcomes. Methods: A retrospective study was conducted at the National Scientific Center of Surgery named after A.N. Syzganov in Almaty, Kazakhstan, between January 2019 and December 2024. The study included 481 patients diagnosed with VVD, divided into two groups: Group I (n=305) underwent traditional surgical treatment (ligation and vein stripping), while Group II (n=176) received minimally invasive interventions (EVLA, RFA, or sclerotherapy). Data on demographics, CEAP classification, Doppler ultrasound parameters, intraoperative characteristics, postoperative complications, and recovery time were analyzed. Statistical analysis was performed using t-test, chi-square test, and logistic regression (p<0.05). Results: Minimally invasive methods showed significantly shorter operative times (43.2 vs. 78.6 min), less intraoperative blood loss (48.9 vs. 160.3 ml), and fewer complications (6.8% vs. 16.9%). Postoperative pain (VAS) and hospital stay were significantly lower in the minimally invasive group. However, traditional surgery was more often used in advanced cases (C3–C4 stages). Conclusion: Minimally invasive surgical methods for VVD are associated with fewer complications, faster recovery, and greater patient satisfaction. However, traditional approaches remain essential in severe cases. Individualized treatment planning based on clinical stage and patient characteristics is key to achieving optimal outcomes.
- Open Access
- 30 June 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(27),p. 143-150
ANALYSIS OF TREATMENT OUTCOMES FOR BLEEDING FROM ESOPHAGEAL AND GASTRIC VARICES
Introduction.Bleedingfromesophagealandgastricvarices(EGV)isoneofthemostlife-threateningcomplicationsoflivercirrhosisandportalhypertension,associatedwithhighmortality,especiallyincasesoflatediagnosisandadvancedhepaticinsufficiency. Aim.ToevaluatetheclinicalcharacteristicsandtreatmentoutcomesofpatientswithEGVbleedingtreatedattheSurgicalDepartmentoftheEmergencyCityHospitalinAlmatyfrom2022to2024. MaterialsandMethods.Тhestudyincluded162patients.Clinicalparameters,severityofcirrhosis(Child–Pughscore),MELDindex,endoscopicclassificationofvarices(JGES),andtreatmentoutcomeswereanalyzed.Descriptivestatistics,Student’st-test,χ²-test,andone-wayANOVAwereused.Oddsratios(OR)with95%confidenceintervalswerecalculatedtoassessriskfactorsforrebleeding.Ap-value<0.05wasconsideredstatisticallysignificant. Results.Among162patients,malespredominated(55.6%),withameanageof54.3 ± 11.2years.Anemia(<70g/L)wasdetectedin62.3%.II–IIIdegreevariceswerediagnosedin95.1%,andChild–PughclassesBandCwerepresentin69.7%.Earlyligation(<24hours)reducedrebleedingto2.3%,comparedto12.5%withdelayedintervention(OR = 2.32);presenceofredcolorsigns(RCS)increasedrebleedingriskto17.9%(OR = 6.51).Overallmortalitywas4.32%,postoperativemortality—1.2%;allfataloutcomesoccurredinpatientswithseverehepaticdysfunction.Conclusions.EGVbleedingremainsaseverecomplicationofcirrhosisrequiringpromptdiagnosisandactivetreatment.Earlyendoscopicligationeffectivelyreducestheriskofrebleedingandmortality.ThepresenceofRCSandadvancedvaricealgradearesignificantpredictorsofpoorprognosis. Введение. Кровотечение из варикозно-расширенных вен (ВРВ) пищевода и желудка является одним из наиболее опасных осложнений цирроза печени и портальной гипертензии, сопровождающимся высокой летальностью при поздней диагностике и тяжёлой печёночной недостаточности. Цель. Оценить клинические характеристики и результаты лечения пациентов с кровотечением из ВРВ пищевода и желудка, пролеченных в хирургическом отделении ГБСНП г. Алматы в 2022–2024 гг. Материалы и методы. В исследование включены 162 пациента. Изучены клинические данные, тяжесть цирроза по шкале Child–Pugh, уровень MELD, эндоскопическая характеристика ВРВ (по классификации JGES), результатов лечения.Применялись методы описательной статистики, t-критерий Стьюдента, χ²-тест, однофакторный ANOVA. Для оценки факторов риска рецидива кровотечения рассчитывались отношения шансов (OR) с 95% доверительными интервалами. Значение p< 0,05 считалось статистически значимым. Результаты.Среди 162 пациентов с ВРВ пищевода и желудка преобладали мужчины (55,6%), средний возраст — 54,3 ± 11,2 лет. У 62,3% пациентоввыявленаанемия(<70 г/л). II–IIIстепеньВРВдиагностированау 95,1%, классыBиCпоChild–Pugh—у 69,7%. Раннеелигирование (<24 ч) снижалорецидивдо 2,3%, при≥24 ч—до 12,5% (OR = 2,32); наличиекрасных маркеров (RCS) повышало риск рецидива до 17,9% (OR = 6,51). Общаялетальностьсоставила4,32%, послеоперационная— 1,2%; всеслучаилетальногоисходазарегистрированыпритяжёлойпечёночнойнедостаточности. Выводы:Кровотечение из ВРВ пищевода и желудка требует своевременной диагностики и активной тактики. Раннее эндоскопическое лигирование эффективно снижает риск рецидива и летальности. Наличие RCS и IIIстепень ВРВ являются значимыми предикторами неблагоприятного течения. Кіріспе.Өңешпенасқазанныңварикоздыкеңейгенвеналарынан (ВКВ) туындайтынқанкету—бауырциррозыменпортальдыгипертензияныңеңқауіптіасқынуларыныңбірі. Бұлжағдай, әсіреседиагноздыңкешқойылуындажәнебауырқызметініңауыржеткіліксіздігі кезінде, жоғарыөлім-жітімменсипатталады. Мақсаты. Алматы қалалықжеделшұғылкөмеккөрсетуауруханасыхирургиябөлімінде 2022–2024 жылдараралығындаВКВ-нанқанкетудиагнозыменемделгеннауқастардыңклиникалықсипаттамаларынжәнеемдеунәтижелерінбағалау. Материалдар мен тәсілдер. Зерттеуге ВКВ-нан қанкеткен 162 науқасенгізілді. Клиникалықдеректер, цирроздыңауырлығы (Child–Pugh шкаласыбойынша), MELD индексі, эндоскопиялықжіктеу (JGES), емдеунәтижелерізерттелді. Деректергесипаттамалықстатистика, Стьюденттің...
- 30 June 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(27),p. 143-150
Open AccessANALYSIS OF TREATMENT OUTCOMES FOR BLEEDING FROM ESOPHAGEAL AND GASTRIC VARICES
Introduction.Bleedingfromesophagealandgastricvarices(EGV)isoneofthemostlife-threateningcomplicationsoflivercirrhosisandportalhypertension,associatedwithhighmortality,especiallyincasesoflatediagnosisandadvancedhepaticinsufficiency. Aim.ToevaluatetheclinicalcharacteristicsandtreatmentoutcomesofpatientswithEGVbleedingtreatedattheSurgicalDepartmentoftheEmergencyCityHospitalinAlmatyfrom2022to2024. MaterialsandMethods.Тhestudyincluded162patients.Clinicalparameters,severityofcirrhosis(Child–Pughscore),MELDindex,endoscopicclassificationofvarices(JGES),andtreatmentoutcomeswereanalyzed.Descriptivestatistics,Student’st-test,χ²-test,andone-wayANOVAwereused.Oddsratios(OR)with95%confidenceintervalswerecalculatedtoassessriskfactorsforrebleeding.Ap-value<0.05wasconsideredstatisticallysignificant. Results.Among162patients,malespredominated(55.6%),withameanageof54.3 ± 11.2years.Anemia(<70g/L)wasdetectedin62.3%.II–IIIdegreevariceswerediagnosedin95.1%,andChild–PughclassesBandCwerepresentin69.7%.Earlyligation(<24hours)reducedrebleedingto2.3%,comparedto12.5%withdelayedintervention(OR = 2.32);presenceofredcolorsigns(RCS)increasedrebleedingriskto17.9%(OR = 6.51).Overallmortalitywas4.32%,postoperativemortality—1.2%;allfataloutcomesoccurredinpatientswithseverehepaticdysfunction.Conclusions.EGVbleedingremainsaseverecomplicationofcirrhosisrequiringpromptdiagnosisandactivetreatment.Earlyendoscopicligationeffectivelyreducestheriskofrebleedingandmortality.ThepresenceofRCSandadvancedvaricealgradearesignificantpredictorsofpoorprognosis. Введение. Кровотечение из варикозно-расширенных вен (ВРВ) пищевода и желудка является одним из наиболее опасных осложнений цирроза печени и портальной гипертензии, сопровождающимся высокой летальностью при поздней диагностике и тяжёлой печёночной недостаточности. Цель. Оценить клинические характеристики и результаты лечения пациентов с кровотечением из ВРВ пищевода и желудка, пролеченных в хирургическом отделении ГБСНП г. Алматы в 2022–2024 гг. Материалы и методы. В исследование включены 162 пациента. Изучены клинические данные, тяжесть цирроза по шкале Child–Pugh, уровень MELD, эндоскопическая характеристика ВРВ (по классификации JGES), результатов лечения.Применялись методы описательной статистики, t-критерий Стьюдента, χ²-тест, однофакторный ANOVA. Для оценки факторов риска рецидива кровотечения рассчитывались отношения шансов (OR) с 95% доверительными интервалами. Значение p< 0,05 считалось статистически значимым. Результаты.Среди 162 пациентов с ВРВ пищевода и желудка преобладали мужчины (55,6%), средний возраст — 54,3 ± 11,2 лет. У 62,3% пациентоввыявленаанемия(<70 г/л). II–IIIстепеньВРВдиагностированау 95,1%, классыBиCпоChild–Pugh—у 69,7%. Раннеелигирование (<24 ч) снижалорецидивдо 2,3%, при≥24 ч—до 12,5% (OR = 2,32); наличиекрасных маркеров (RCS) повышало риск рецидива до 17,9% (OR = 6,51). Общаялетальностьсоставила4,32%, послеоперационная— 1,2%; всеслучаилетальногоисходазарегистрированыпритяжёлойпечёночнойнедостаточности. Выводы:Кровотечение из ВРВ пищевода и желудка требует своевременной диагностики и активной тактики. Раннее эндоскопическое лигирование эффективно снижает риск рецидива и летальности. Наличие RCS и IIIстепень ВРВ являются значимыми предикторами неблагоприятного течения. Кіріспе.Өңешпенасқазанныңварикоздыкеңейгенвеналарынан (ВКВ) туындайтынқанкету—бауырциррозыменпортальдыгипертензияныңеңқауіптіасқынуларыныңбірі. Бұлжағдай, әсіреседиагноздыңкешқойылуындажәнебауырқызметініңауыржеткіліксіздігі кезінде, жоғарыөлім-жітімменсипатталады. Мақсаты. Алматы қалалықжеделшұғылкөмеккөрсетуауруханасыхирургиябөлімінде 2022–2024 жылдараралығындаВКВ-нанқанкетудиагнозыменемделгеннауқастардыңклиникалықсипаттамаларынжәнеемдеунәтижелерінбағалау. Материалдар мен тәсілдер. Зерттеуге ВКВ-нан қанкеткен 162 науқасенгізілді. Клиникалықдеректер, цирроздыңауырлығы (Child–Pugh шкаласыбойынша), MELD индексі, эндоскопиялықжіктеу (JGES), емдеунәтижелерізерттелді. Деректергесипаттамалықстатистика, Стьюденттің...
- Open Access
- 28 February 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 1(27),p. 66-74
NON-VARICOSE BLEEDING FROM THE UPPER GASTROINTESTINAL TRACT
Introduction. Non-variceal upper gastrointestinal bleeding (NVUGIB) is one of the most critical issues in emergency surgery. This pathology is characterized by a high prevalence and significant mortality rates, especially among elderly patients and individuals with comorbid conditions. Aim. To study the treatment outcomes of patients with non-variceal upper gastrointestinal bleeding. Materials and methods. A retrospective study was conducted among n = 667 patients who received inpatient treatment at the surgical department of the City Emergency Hospital in Almaty from January 1, 2019, to December 31, 2023. Mean values (M ± m) and differences between arithmetic means were assessed using Student’s t-test. The relationship between clinical parameters and outcomes was evaluated using the chi-square (χ²) test. Risk factors for adverse outcomes (mortality, rebleeding, need for surgical treatment) were analyzed using logistic regression. The impact of factors was assessed by calculating the odds ratio (OR) with a 95% confidence interval (95% CI). A p-value < 0.05 was considered statistically significant. Results. The primary causes of bleeding were acute ulcers (60.4%), Mallory-Weiss syndrome (20.4%), chronic ulcers (13.2%), and bleeding of unknown etiology (6.0%). According to the Forrest classification, the most common form was IIB (54.5%). The overall rebleeding rate was 6.9%, while the total mortality rate was 3.6%. Mortality rates by etiology were as follows: acute ulcers – 2.7%, chronic ulcers – 5.6%, Mallory-Weiss syndrome – 0.7%, and bleeding of unknown etiology – 17.5%. The average surgical intervention rate during the study period was 2.8%. Conclusions. Thus, non-variceal upper gastrointestinal bleeding remains a pressing issue in gastroenterology and surgery, requiring a comprehensive approach to diagnosis and treatment. The study confirmed the high prevalence of peptic ulcer disease, Mallory-Weiss syndrome, and erosive lesions as leading causes of bleeding. The main risk factors for NVUGIB include the use of anticoagulants, nonsteroidal anti-inflammatory drugs, and cardiovascular diseases, highlighting the necessity of careful medication management in patients at high risk of bleeding. Введение. Неварикозные кровотечения из верхних отделов желудочно-кишечного тракта (НВК ВОЖКТ) — одна из важнейших проблем в экстренной хирургии. Данная патология характеризуется высокой распространённостью и значительными показателями летальности, особенно среди пациентов старших возрастных групп и лиц с сопутствующими патологиями. Цель. Изучение результатов лечения пациентов с неварикозными кровотечениями из верхних отделов желудочно-кишечного тракта. Материалы и методы. Ретроспективное исследование проведено среди n=667 пациентов, получивших стационарное лечение в хирургическом отделении Городской больницы скорой неотложной помощи г. Алматы в период с 1 января 2019 года по 31 декабря 2023 года. Средние значения (М±m) и различия между средними арифметическими величинами оценивались с использованием критерия Стьюдента (t). Для оценки связи между клиническими параметрами и результатами использовался критерий χ² (хи-квадрат). Оценка факторов риска развития неблагоприятных исходов (летальности, рецидива кровотечения, потребности в хирургическом лечении) проводилась с использованием логистической регрессии. Влияние факторов оценивалось путем расчета отношения шансов (OR) с 95% доверительным интервалом (95% ДИ). Значение p<0,05 считалось статистически значимым. Результаты. Основными причинами кровотечений были острые язвы (60,4%), синдром Мэллори-Вейса (20,4%), хронические язвы (13,2%) и кровотечения неизвестной этиологии (6,0%). По классификации Forrest наиболее часто встречалась форма IIB (54,5%). Общий уровень рецидив кровотечений составил 6,9%, а общая летальность — 3,6%. Всего летальность составила 3,6%. Из них при острых язвах — 2,7%, хронических язвах — 5,6%, синдроме Мэллори-Вейса — 0,7%, кровотечениях неясной этиологии — 17,5%. Хирургическая активность в исследуемый период составила в среднем 2,8%. Выводы. Таким образом, неварикозное кровотечение из верхних отделов желудочно-кишечного тракта остается актуальной проблемой гастроэнтерологии и хирургии, требующей комплексного подхода к диагностике и лечению. Проведенное исследование...
- 28 February 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 1(27),p. 66-74
Open AccessNON-VARICOSE BLEEDING FROM THE UPPER GASTROINTESTINAL TRACT
Introduction. Non-variceal upper gastrointestinal bleeding (NVUGIB) is one of the most critical issues in emergency surgery. This pathology is characterized by a high prevalence and significant mortality rates, especially among elderly patients and individuals with comorbid conditions. Aim. To study the treatment outcomes of patients with non-variceal upper gastrointestinal bleeding. Materials and methods. A retrospective study was conducted among n = 667 patients who received inpatient treatment at the surgical department of the City Emergency Hospital in Almaty from January 1, 2019, to December 31, 2023. Mean values (M ± m) and differences between arithmetic means were assessed using Student’s t-test. The relationship between clinical parameters and outcomes was evaluated using the chi-square (χ²) test. Risk factors for adverse outcomes (mortality, rebleeding, need for surgical treatment) were analyzed using logistic regression. The impact of factors was assessed by calculating the odds ratio (OR) with a 95% confidence interval (95% CI). A p-value < 0.05 was considered statistically significant. Results. The primary causes of bleeding were acute ulcers (60.4%), Mallory-Weiss syndrome (20.4%), chronic ulcers (13.2%), and bleeding of unknown etiology (6.0%). According to the Forrest classification, the most common form was IIB (54.5%). The overall rebleeding rate was 6.9%, while the total mortality rate was 3.6%. Mortality rates by etiology were as follows: acute ulcers – 2.7%, chronic ulcers – 5.6%, Mallory-Weiss syndrome – 0.7%, and bleeding of unknown etiology – 17.5%. The average surgical intervention rate during the study period was 2.8%. Conclusions. Thus, non-variceal upper gastrointestinal bleeding remains a pressing issue in gastroenterology and surgery, requiring a comprehensive approach to diagnosis and treatment. The study confirmed the high prevalence of peptic ulcer disease, Mallory-Weiss syndrome, and erosive lesions as leading causes of bleeding. The main risk factors for NVUGIB include the use of anticoagulants, nonsteroidal anti-inflammatory drugs, and cardiovascular diseases, highlighting the necessity of careful medication management in patients at high risk of bleeding. Введение. Неварикозные кровотечения из верхних отделов желудочно-кишечного тракта (НВК ВОЖКТ) — одна из важнейших проблем в экстренной хирургии. Данная патология характеризуется высокой распространённостью и значительными показателями летальности, особенно среди пациентов старших возрастных групп и лиц с сопутствующими патологиями. Цель. Изучение результатов лечения пациентов с неварикозными кровотечениями из верхних отделов желудочно-кишечного тракта. Материалы и методы. Ретроспективное исследование проведено среди n=667 пациентов, получивших стационарное лечение в хирургическом отделении Городской больницы скорой неотложной помощи г. Алматы в период с 1 января 2019 года по 31 декабря 2023 года. Средние значения (М±m) и различия между средними арифметическими величинами оценивались с использованием критерия Стьюдента (t). Для оценки связи между клиническими параметрами и результатами использовался критерий χ² (хи-квадрат). Оценка факторов риска развития неблагоприятных исходов (летальности, рецидива кровотечения, потребности в хирургическом лечении) проводилась с использованием логистической регрессии. Влияние факторов оценивалось путем расчета отношения шансов (OR) с 95% доверительным интервалом (95% ДИ). Значение p<0,05 считалось статистически значимым. Результаты. Основными причинами кровотечений были острые язвы (60,4%), синдром Мэллори-Вейса (20,4%), хронические язвы (13,2%) и кровотечения неизвестной этиологии (6,0%). По классификации Forrest наиболее часто встречалась форма IIB (54,5%). Общий уровень рецидив кровотечений составил 6,9%, а общая летальность — 3,6%. Всего летальность составила 3,6%. Из них при острых язвах — 2,7%, хронических язвах — 5,6%, синдроме Мэллори-Вейса — 0,7%, кровотечениях неясной этиологии — 17,5%. Хирургическая активность в исследуемый период составила в среднем 2,8%. Выводы. Таким образом, неварикозное кровотечение из верхних отделов желудочно-кишечного тракта остается актуальной проблемой гастроэнтерологии и хирургии, требующей комплексного подхода к диагностике и лечению. Проведенное исследование...
- 1 October 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (3) , 10-18
RESULTS OF GASTROINTESTINAL BLEEDING TREATMENT IN THE REPUBLIC OF KAZAKHSTAN OVER 10 YEARS
Gastrointestinal bleeding (GIB) remains a significant cause of hospitalization and mortality worldwide, including in Kazakhstan. This retrospective study analyzes the incidence, treatment outcomes, and mortality of GIB in the Republic of Kazakhstan over a 10-year period (2014–2023) using data from 101,703 patients across 254 medical institutions. The study differentiates between non-variceal and variceal GIB, highlighting a 24.5% increase in non-variceal cases and a 45.1% increase in variceal cases due to higher rates of acute ulcerative lesions and liver cirrhosis, respectively. Men were disproportionately affected, accounting for 69.3% of cases, with the highest incidence in the 18-59 age group. Despite a 27.8% increase in GIB cases, overall mortality decreased from 7.8% in 2014 to 5.0% in 2023, largely due to advances in endoscopic hemostasis and critical care management. The mortality rate for non-variceal GIB decreased to 3.0%, while variceal GIB decreased from 23.8% to 13.6%. The results underscore the need for improved prevention, especially in high-risk populations using NSAIDs and anticoagulants, and in those with chronic conditions such as liver disease.
- 1 October 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (3) , 10-18
RESULTS OF GASTROINTESTINAL BLEEDING TREATMENT IN THE REPUBLIC OF KAZAKHSTAN OVER 10 YEARS
Gastrointestinal bleeding (GIB) remains a significant cause of hospitalization and mortality worldwide, including in Kazakhstan. This retrospective study analyzes the incidence, treatment outcomes, and mortality of GIB in the Republic of Kazakhstan over a 10-year period (2014–2023) using data from 101,703 patients across 254 medical institutions. The study differentiates between non-variceal and variceal GIB, highlighting a 24.5% increase in non-variceal cases and a 45.1% increase in variceal cases due to higher rates of acute ulcerative lesions and liver cirrhosis, respectively. Men were disproportionately affected, accounting for 69.3% of cases, with the highest incidence in the 18-59 age group. Despite a 27.8% increase in GIB cases, overall mortality decreased from 7.8% in 2014 to 5.0% in 2023, largely due to advances in endoscopic hemostasis and critical care management. The mortality rate for non-variceal GIB decreased to 3.0%, while variceal GIB decreased from 23.8% to 13.6%. The results underscore the need for improved prevention, especially in high-risk populations using NSAIDs and anticoagulants, and in those with chronic conditions such as liver disease.
- 28 June 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (2) , 61-77
WHAT SCALES SHOULD THE CARDIOLOGIST USE IN PATIENTS WITH ATRIAL FIBRILLATION? WHAT IS NEW?
The current treatment algorithm for patients with non-valvular atrial fibrillation (AF) includes anticoagulation to prevent stroke and systemic embolism, improvement of AF symptom control by heart rate reduction or restoration and maintenance of sinus rhythm, and treatment of cardiovascular and other comorbidities. The evaluation of patients with AF should be structured and include assessment of stroke risk, symptom severity, severity of the AF burden (type of arrhythmia, number and duration of episodes, etc.) and predisposing condition. The use of the CHA2DS2-VASc (risk of stroke), HAS-BLED (risk of bleeding), EHRA (severity of AF symptoms), and 2MACE (risk of cardiovascular outcomes) scales is important to help assess the likelihood of adverse outcomes and select the optimal treatment to protect not only against stroke but also against cardiovascular events. It should be noted that the HAS-BLED scale is primarily necessary for identification of bleeding risk factors, the modification of which allows to increase the safety of anticoagulant therapy, and a high index value according to this scale can’t serve as a reason to refuse anticoagulation in a patient with AF. New scales of stroke and hemorrhagic complications risk assessment in patients with AF on the basis of clinical parameters and laboratory biomarkers have been proposed, but their possible advantages over the existing indices need to be confirmed in special studies
- 28 June 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (2) , 61-77
WHAT SCALES SHOULD THE CARDIOLOGIST USE IN PATIENTS WITH ATRIAL FIBRILLATION? WHAT IS NEW?
The current treatment algorithm for patients with non-valvular atrial fibrillation (AF) includes anticoagulation to prevent stroke and systemic embolism, improvement of AF symptom control by heart rate reduction or restoration and maintenance of sinus rhythm, and treatment of cardiovascular and other comorbidities. The evaluation of patients with AF should be structured and include assessment of stroke risk, symptom severity, severity of the AF burden (type of arrhythmia, number and duration of episodes, etc.) and predisposing condition. The use of the CHA2DS2-VASc (risk of stroke), HAS-BLED (risk of bleeding), EHRA (severity of AF symptoms), and 2MACE (risk of cardiovascular outcomes) scales is important to help assess the likelihood of adverse outcomes and select the optimal treatment to protect not only against stroke but also against cardiovascular events. It should be noted that the HAS-BLED scale is primarily necessary for identification of bleeding risk factors, the modification of which allows to increase the safety of anticoagulant therapy, and a high index value according to this scale can’t serve as a reason to refuse anticoagulation in a patient with AF. New scales of stroke and hemorrhagic complications risk assessment in patients with AF on the basis of clinical parameters and laboratory biomarkers have been proposed, but their possible advantages over the existing indices need to be confirmed in special studies
- 22 December 2023
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 4,p. 4-16
Diagnosis and modern treatment methods for hepatic hemangioma (literature review)
Background. Hepatic hemangioma is the most common form among benign liver tumors. The vast majority is asymptomatic, usually detected accidentally during screening. A thorough study is required to distinguish it from other local liver pathologies, therefore, in the review paper below we have analyzed important issues during the diagnosis and treatment of liver hemangioma in international experience. The aim of this study differentiation of modern methods of diagnosis and treatment of liver hemangioma in clinical practice. Material and methods. In the review work, a literature review of randomized, meta-analyses, clinical trials and international clinical recommendations in English and Russian, published only from January 2010 to August 2023 in bibliographic and other electronic medical databases such as PubMed, Scopus, Web of Science, GoogleScholarship, Springer, rare clinical cases were carried out. Criteria for inclusion in the study: 1) full-text research published in the database; 2) research in English or Russian; 3) research carried out or published in the last 2010-2023 years. Conclusions. As the most common benign liver tumor, the incidence of hepatic hemangioma during autopsy is from 0.4 to 20%. Most hepatic hemangiomas are asymptomatic, small-sized forms do not require intervention. Liver hemangioma can be easily diagnosed using ultrasound, or cop phase spiral contrast computer tomography. An indication for surgical resection is a feeling of progressive pain in the abdomen and a size of more than 5 cm. Some patients also have giant hemangiomas with minimal symptomatic. Giant hemangiomas (>10cm) are most often manifested by symptoms and require mandatory surgical intervention. The most commonly used method for the treatment of hemangiomas today is transaortic embolization, surgical resection. But to date, there is no consensus on the best treatment for patients with symptomatic and/or large hemangiomas.
- 22 December 2023
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 4,p. 4-16
Diagnosis and modern treatment methods for hepatic hemangioma (literature review)
Background. Hepatic hemangioma is the most common form among benign liver tumors. The vast majority is asymptomatic, usually detected accidentally during screening. A thorough study is required to distinguish it from other local liver pathologies, therefore, in the review paper below we have analyzed important issues during the diagnosis and treatment of liver hemangioma in international experience. The aim of this study differentiation of modern methods of diagnosis and treatment of liver hemangioma in clinical practice. Material and methods. In the review work, a literature review of randomized, meta-analyses, clinical trials and international clinical recommendations in English and Russian, published only from January 2010 to August 2023 in bibliographic and other electronic medical databases such as PubMed, Scopus, Web of Science, GoogleScholarship, Springer, rare clinical cases were carried out. Criteria for inclusion in the study: 1) full-text research published in the database; 2) research in English or Russian; 3) research carried out or published in the last 2010-2023 years. Conclusions. As the most common benign liver tumor, the incidence of hepatic hemangioma during autopsy is from 0.4 to 20%. Most hepatic hemangiomas are asymptomatic, small-sized forms do not require intervention. Liver hemangioma can be easily diagnosed using ultrasound, or cop phase spiral contrast computer tomography. An indication for surgical resection is a feeling of progressive pain in the abdomen and a size of more than 5 cm. Some patients also have giant hemangiomas with minimal symptomatic. Giant hemangiomas (>10cm) are most often manifested by symptoms and require mandatory surgical intervention. The most commonly used method for the treatment of hemangiomas today is transaortic embolization, surgical resection. But to date, there is no consensus on the best treatment for patients with symptomatic and/or large hemangiomas.
- 22 December 2023
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 4,p. 45-51
Transabdominal bowel ultrasound as a method of primary diagnosis in acute bowel pathology: literature review and demonstration of clinical cases
Currently, transabdominal ultrasound of the bowel is rarely used in daily routine practice to assess bowel condition due to the difficulty of its visualization, lack of awareness of specialists, and also due to the limited number of specialists who know the technique of bowel examination. Patients with acute bowel pathology seek emergency care in more than one third of cases. Gastrointestinal ultrasound is often used as the first imaging modality with good diagnostic accuracy in the setting of acute abdomen and may be the optimal diagnostic strategy in young women because of the radiation burden associated with X-ray and computer tomography scan. The clinician can examine the gastrointestinal tract in the area of greatest pain using ultrasound, thus obtaining more information and pathology data than standard physical examination. Intestinal ultrasound is mainly used for the diagnosis and monitoring of patients with inflammatory bowel disease, which helps to avoid the frequent use of invasive and expensive diagnostic procedures and leads to the early implementation of suitable treatment. This method can also serve to detect other pathological conditions present in the gastrointestinal tract. It is a promising method with high sensitivity and specificity, which has the advantage of being easily accessible, non-invasive, safe, due to the absence of ionising radiation and the need to use contrast agents. In addition, the advantage of this method is the reduction of diagnostic search, which allows the doctor to establish the diagnosis in a shorter time, as well as to reduce the patient’s expenses for expensive examinations.
- 22 December 2023
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 4,p. 45-51
Transabdominal bowel ultrasound as a method of primary diagnosis in acute bowel pathology: literature review and demonstration of clinical cases
Currently, transabdominal ultrasound of the bowel is rarely used in daily routine practice to assess bowel condition due to the difficulty of its visualization, lack of awareness of specialists, and also due to the limited number of specialists who know the technique of bowel examination. Patients with acute bowel pathology seek emergency care in more than one third of cases. Gastrointestinal ultrasound is often used as the first imaging modality with good diagnostic accuracy in the setting of acute abdomen and may be the optimal diagnostic strategy in young women because of the radiation burden associated with X-ray and computer tomography scan. The clinician can examine the gastrointestinal tract in the area of greatest pain using ultrasound, thus obtaining more information and pathology data than standard physical examination. Intestinal ultrasound is mainly used for the diagnosis and monitoring of patients with inflammatory bowel disease, which helps to avoid the frequent use of invasive and expensive diagnostic procedures and leads to the early implementation of suitable treatment. This method can also serve to detect other pathological conditions present in the gastrointestinal tract. It is a promising method with high sensitivity and specificity, which has the advantage of being easily accessible, non-invasive, safe, due to the absence of ionising radiation and the need to use contrast agents. In addition, the advantage of this method is the reduction of diagnostic search, which allows the doctor to establish the diagnosis in a shorter time, as well as to reduce the patient’s expenses for expensive examinations.
- 1 June 2023
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- p. 54-61
MODERN METHODS OF DIAGNOSIS AND TREATMENT OF ACUTE PANCREATITIS. LITERATURE REVIEW
Purpose. Differentiation of modern methods of diagnosis and treatment of acute pancreatitis in clinical practice. A literature review of foreign randomized clinical trials and meta-analysis, international clinical recommendations of the PubMed electronic database for the period from 2002 to 2022 was conducted. 28 relevant articles on the topic of the review were selected from them. Conclusions. Thus, using one method or one scale, it is impossible to predict the severity of acute pancreatitis in the first hospitalization hours. This days the treatment of acute pancreatitis is based on the latest international recommendations developed by the International Association of Pancreatology (IAP) and the American Pancreatic Association (APA). According to this guide, we believe that acute pancreatitis needs to be diagnosed and treated, also there is a need a number of randomized large- scale surgical trials of acute pancreatitis which have to be conducted.
- 1 June 2023
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- p. 54-61
MODERN METHODS OF DIAGNOSIS AND TREATMENT OF ACUTE PANCREATITIS. LITERATURE REVIEW
Purpose. Differentiation of modern methods of diagnosis and treatment of acute pancreatitis in clinical practice. A literature review of foreign randomized clinical trials and meta-analysis, international clinical recommendations of the PubMed electronic database for the period from 2002 to 2022 was conducted. 28 relevant articles on the topic of the review were selected from them. Conclusions. Thus, using one method or one scale, it is impossible to predict the severity of acute pancreatitis in the first hospitalization hours. This days the treatment of acute pancreatitis is based on the latest international recommendations developed by the International Association of Pancreatology (IAP) and the American Pancreatic Association (APA). According to this guide, we believe that acute pancreatitis needs to be diagnosed and treated, also there is a need a number of randomized large- scale surgical trials of acute pancreatitis which have to be conducted.